Financhill
Buy
56

BIO Quote, Financials, Valuation and Earnings

Last price:
$342.96
Seasonality move :
8.24%
Day range:
$341.38 - $345.76
52-week range:
$262.12 - $387.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.77x
P/B ratio:
1.28x
Volume:
122.4K
Avg. volume:
169.7K
1-year change:
12.59%
Market cap:
$9.6B
Revenue:
$2.7B
EPS (TTM):
-$27.33

Earnings Data

Next earnings date for BIO
Feb 14
2025
Most recent earnings per share
$23.34
Beat by $22.16
(Oct 30/2024)
Consensus Estimate
$1.18
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $622.2M -- -- $2.64 --
02/14/2025 Q4 $680.6M -- -- $2.89 --
10/30/2024 Q3 $628.6M $649.7M $23.34 $1.18 $22.16
08/01/2024 Q2 $646.4M $638.5M -$76.26 $2.02 -$78.28
05/07/2024 Q1 $620.1M $610.8M $13.45 $2.14 $11.31
02/15/2024 Q4 $686.6M $681.2M $12.14 $2.87 $9.27
10/26/2023 Q3 -- -- $3.64 $2.81 $0.83
08/03/2023 Q2 -- -- -$39.59 $2.68 -$42.27
05/04/2023 Q1 -- -- $2.32 $3.48 -$1.16
02/16/2023 Q4 -- -- $27.78 $3.44 $24.34
10/27/2022 Q3 -- -- -$5.52 $2.77 -$8.29
07/28/2022 Q2 -- -- -$31.12 $2.77 -$33.89
04/28/2022 Q1 -- -- -$112.57 $3.23 -$115.80
02/10/2022 Q4 -- -- -$52.59 $2.87 -$55.46
10/28/2021 Q3 -- -- $129.96 $2.48 $127.48
07/29/2021 Q2 -- -- $30.32 $2.70 $27.62
04/29/2021 Q1 -- -- $32.38 $2.94 $29.44
02/11/2021 Q4 -- -- $27.81 $3.32 $24.49
10/29/2020 Q3 -- -- $43.64 $1.82 $41.82
07/30/2020 Q2 -- -- $32.15 $1.15 $31.00
05/06/2020 Q1 -- -- $22.72 $1.57 $21.15
02/13/2020 Q4 -- -- $18.31 $2.45 $15.86
10/31/2019 Q3 -- -- -$8.68 $1.41 -$10.09
08/01/2019 Q2 -- -- -- $1.34 --
05/08/2019 Q1 -- -- -- $1.09 --
02/28/2019 Q4 -- -- -- $1.73 --
11/01/2018 Q3 -- -- -- $1.14 --
08/07/2018 Q2 -- -- -- -- --
05/08/2018 Q1 -- -- -- -- --
02/27/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- -- -- --
08/03/2017 Q2 -- -- -- -- --
05/04/2017 Q1 -- -- -- -- --
02/23/2017 Q4 -- -- -- -- --
11/01/2016 Q3 -- -- -- -- --
08/03/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
02/25/2016 Q4 -- -- -- -- --
11/03/2015 Q3 -- -- -- -- --
08/06/2015 Q2 -- -- -- -- --
05/05/2015 Q1 -- -- -- -- --

Bio-Rad Laboratories Earnings Questions

  • How Much did Bio-Rad Laboratories Generate in Revenue Last Quarter?

    Bio-Rad Laboratories reported $649.7M worth of top line sales in its most recent quarter.

  • Did Bio-Rad Laboratories Beat Earnings Last Quarter?

    Bio-Rad Laboratories announced earnings per share of $23.34 which represents a beat of analyst forecast a $1.18 per share.

  • Is Bio-Rad Laboratories Profitable?

    Bio-Rad Laboratories reported $355.9M that represents $12.72 per share over the last quarter.

  • What is the Analyst Consensus for Bio-Rad Laboratories EPS Next Year?

    Bio-Rad Laboratories's earnings are forecast to grow from -$21.82 per share to $10.06 per share next year representing an increase of --.

  • When is Bio-Rad Laboratories's Earnings Date?

    Bio-Rad Laboratories's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is AT&T Stock Dropping?
Why Is AT&T Stock Dropping?

The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…

Is American Express Stock Going Lower?
Is American Express Stock Going Lower?

American Express Company (NYSE:AXP) has long been a Buffett favorite…

Cigna vs Costco Stock: Which Is Best?
Cigna vs Costco Stock: Which Is Best?

Cigna and Costco don’t usually go hand in hand but…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 18

Quantum [QMCO] is down 15.61% over the past day.

Buy
51
QRVO alert for Jan 18

Qorvo [QRVO] is up 14.47% over the past day.

Sell
31
ATEX alert for Jan 18

Anterix [ATEX] is up 11.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock